(UroToday.com) In a session at the American Society for Radiation Oncology (ASTRO) Annual Congress focused on the care of patients with intermediate and high-risk prostate cancer, Dr. Romero presented on the relationship between androgen deprivation therapy (ADT) duration and external beam radiotherapy (EBRT) with or without brachytherapy boost in high-risk prostate cancer.